News

As per the agreement, Merck receives worldwide rights to develop and commercialize biotherapeutic drug conjugates aimed at a number of pre-specified targets while Ambrx will earn $15m upfront

The new system, which is available in single-, twin-, triplet-, and quad-vessel configurations, is flexible to handle volumes from 4l to 10l. The XDR-10 is an integral component

Sanofi Pasteur already kept approximately 1,000 vials of the vaccine out of circulation and another 4,700 vials on the market are being immediately recalled. BCG is used to

The clean room, within its Houston, Texas operations, supports viral-based GMP manufacturing projects of up to 2,000l working volumes. Lonza viral-based therapeutics head David Enloe said the clients’

Based on the data from interim analysis the company decided to discontinue the double-blind, placebo-controlled study. The randomized study was designed to evaluate the efficacy and safety of

The CoolBox XT technology, which does not require power, can be used as an alternative to the ice bucket. The patent-pending technology reduces ice-related issues such as sample

The patent at issue in the case covers the active ingredient in Nasonex, mometasone furoate monohydrate. The patent provides exclusivity for this form of mometasone until 3 April

Janssen-Cilag International NV has also sent a type II variation to the European Medicines Agency (EMA) for approval. The two applications are intended to increase the uses of

CVT-301 provides immediate onset of a large and precise dose of L-dopa. The Phase 2a study is a randomized, placebo-controlled, single dose, cross-over design that will feature the